{"id":"NCT03686384","sponsor":"Salvat","briefTitle":"SVT-15652 Otic Solution for the Treatment of Otomycosis","officialTitle":"A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-02-27","primaryCompletion":"2021-10-25","completion":"2021-10-25","firstPosted":"2018-09-26","resultsPosted":"2023-01-18","lastUpdate":"2024-12-03"},"enrollment":217,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Otomycosis"],"interventions":[{"type":"DRUG","name":"SVT-15652","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"SVT-15652","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Multicenter, randomized, 2-arm parallel-group, double blind, placebo-controlled study in patients suffering from Otomycosis. This study will compare the efficacy and safety of SVT-15652 otic solution to that of Placebo, when administering one vial twice daily during 14 days.","primaryOutcome":{"measure":"Therapeutical Cure (Clinical and Mycological Cure)","timeFrame":"Test of cure on day 24","effectByArm":[{"arm":"SVT-15652","deltaMin":48,"sd":null},{"arm":"Placebo","deltaMin":10,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":134},"commonTop":["Headache","Ear pain"]}}